Details of the Drug
General Information of Drug (ID: DM376J2)
| Drug Name |
D-tartaric acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
d-Tartaric acid; 147-71-7; D-(-)-Tartaric acid; (2S,3S)-2,3-Dihydroxysuccinic acid; D(-)-TARTARIC ACID; (2S,3S)-2,3-dihydroxybutanedioic acid; D-threaric acid; (-)-D-Tartaric acid; (-)-Tartaric acid; (2S,3S)-(-)-Tartaric acid; (S,S)-Tartaric acid; (-)-(S,S)-Tartaric acid; (S,S)-(-)-Tartaric acid; UNII-RRX6A4PL3C; Butanedioic acid, 2,3-dihydroxy-, (2S,3S)-; D-(-)-tartaricacid; (2S,3S)-Tartaric acid; RRX6A4PL3C; CHEBI:15672; MFCD00004238; D-Tartrate; (S,S)-Tartrate; D(-)-Tartaric acid, 99%; levo-Tartaric acid
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 150.09 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -1.9 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 6 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


